v3 Template
G

Gate Bioscience

Biotechnology ~420 employees
Founded
--
Employees (Est.)
~420
21 leaders known
Total Funding
$65.0M
Funding Rounds
1
Last Funding
2025-11-13

About Gate Bioscience

GateBioscience is a company focused on developing Molecular Gates, a new class of small molecule drugs designed to eliminate harmful extracellular proteins at their origin inside cells, preventing them from causing disease. Their mission is to eliminate disease by targeting over 1,000 disease-linked extracellular proteins.

Products & Services

Molecular Gates:Small molecule drugs that selectively block and eliminate disease-causing extracellular proteins by binding to the secretory translocon inside cells, preventing the proteins from being secreted and leading to their degradation.
Molecular Gate Discovery Platform™:A platform combining a library of Molecular Gates, secretion-focused assays, technologies, and expertise in secretory pathway biology to enable precise and rapid drug discovery.

Specialties

Molecular Gates Extracellular Protein Elimination Secretory Pathway Biology Drug Discovery

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B
T: -
FT: Series B 		A: 65000000
MR: -
FA: $65 million
FAN: 65000000 		D: 2025-11-13
FD: 2025-11-13 		6 investors
Series B Latest
2025-11-13
$65.0M
6 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

Jordi Mata-Fink

Chief Executive Officer

LinkedIn (Pro only)
P

Pat Sharp

VP, Research

LinkedIn (Pro only)
R

Raman Talwar

Chief Technology Officer

LinkedIn (Pro only)
B

Brian Cathers

Chief Scientific Officer

N

Nina Oberbeck

VP, Translational Sciences

D

David Wyatt

VP, Discovery Sciences

View 18 more team members with Pro

Unlock Full Team Directory

Recent News

Gate Bioscience Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~420 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro